Nikolay Klimko
Overview
Explore the profile of Nikolay Klimko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kozlova O, Burygina E, Khostelidi S, Shadrivova O, Saturnov A, Gusev D, et al.
J Fungi (Basel)
. 2023 Sep;
9(9).
PMID: 37755035
We studied the risk factors, etiology, clinical manifestations, and treatment outcomes of COVID-19-associated invasive candidiasis (COVID-IC) in adult patients admitted to six medical facilities in St. Petersburg. (November 2020-December 2022)....
2.
Sal E, Stemler J, Salmanton-Garcia J, Falces-Romero I, Kredics L, Meyer E, et al.
J Antimicrob Chemother
. 2022 Aug;
77(10):2850-2858.
PMID: 35929089
Background: Trichoderma spp. are filamentous fungi causing invasive fungal diseases in patients with haematological malignancies and in peritoneal dialysis patients. Objectives: To analyse clinical presentation, predisposing factors, treatment and outcome...
3.
Giacobbe D, Prattes J, Wauters J, Dettori S, Signori A, Salmanton-Garcia J, et al.
J Clin Microbiol
. 2022 Mar;
60(4):e0229821.
PMID: 35321555
Critically ill patients with coronavirus disease 2019 (COVID-19) may develop COVID-19-associated pulmonary aspergillosis (CAPA), which impacts their chances of survival. Whether positive bronchoalveolar lavage fluid (BALF) mycological tests can be...
4.
Shadrivova O, Gusev D, Vashukova M, Lobzin D, Gusarov V, Zamyatin M, et al.
J Fungi (Basel)
. 2021 Dec;
7(12).
PMID: 34947041
We studied the risk factors, etiology, clinical features and the effectiveness of therapy of COVID-19-associated pulmonary aspergillosis (CAPA) in adult patients. In this retrospective study, we included 45 patients with...
5.
Maertens J, Rahav G, Lee D, Ponce-de-Leon A, Ramirez Sanchez I, Klimko N, et al.
Lancet
. 2021 Feb;
397(10273):499-509.
PMID: 33549194
Background: Voriconazole has been recommended as primary treatment for patients with invasive aspergillosis. Intravenous and tablet formulations of posaconazole that have improved systemic absorption could be an effective alternative to...
6.
Koehler P, Bassetti M, Chakrabarti A, Chen S, Colombo A, Hoenigl M, et al.
Lancet Infect Dis
. 2020 Dec;
21(6):e149-e162.
PMID: 33333012
Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary aspergillosis have raised concerns about it worsening the disease course...
7.
Kozlova Y, Frolova E, Uchevatkina A, Filippova L, Aak O, Burygina E, et al.
Mycoses
. 2020 Apr;
63(6):596-603.
PMID: 32246509
Introduction: Allergic bronchopulmonary aspergillosis (ABPA) is a lung disease in patients with asthma or cystic fibrosis (CF) caused by chronic allergic inflammation to Aspergillus spp. antigens. The role of different...
8.
Lanternier F, Seidel D, Pagano L, Styczynski J, Mikulska M, Pulcini C, et al.
Mycoses
. 2020 Feb;
63(5):420-429.
PMID: 32009262
Invasive pulmonary aspergillosis (IPA) optimal duration of antifungal treatment is not known. In a joint effort, four international scientific societies/groups performed a survey to capture current practices in European haematology...
9.
Cornely O, Alastruey-Izquierdo A, Arenz D, Chen S, Dannaoui E, Hochhegger B, et al.
Lancet Infect Dis
. 2019 Nov;
19(12):e405-e421.
PMID: 31699664
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving....
10.
Koehler P, Arendrup M, Arikan-Akdagli S, Bassetti M, Bretagne S, Klingspor L, et al.
Mycoses
. 2019 Jul;
62(10):920-927.
PMID: 31271702
Background: Recent outbreaks of Candida auris further exemplify that invasive Candida infections are a substantial threat to patients and healthcare systems. Even short treatment delays are associated with higher mortality...